Clinical Trial Update: A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type) [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate the effects and safety of hydroxocobalamin in participants with combined methylmalonic acidemia (cblC type); the trial status is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methylmalonic Acidemia

Drugs mentioned

• Hydroxocobalamin (Hydroxocobalamin)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Methylmalonic Acidemia (MMA) | Phase 3 | Status: NOT_YET_RECRUITING